Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer

Fig. 1

A schematic diagram of sample collection in the context of neoadjuvant therapy (NAT) followed by LC-MS, GC-MS metabolomics, transcriptomic RNA sequencing (RNA-seq), and integrated data analyses. T1, the time point at baseline of NAT. T2, the time point after 2 cycles of NAT. T3, the time point after 6 cycles (before surgery) of NAT. BrCa, breast cancer. pCR, pathologic complete response

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us